Spero Therapeutics (2HA.STU) Q2 2026 Earnings

13MayConfirmed
Q2 2026
-0.15
-0.14
-0.13
-0.11

Details

Expected EPS
-0.153612
Actual EPS
-0.11094200000000001
Surprise EPS
0.04
Surprise Percent
+27.78%

Description

Spero Therapeutics (2HA.STU) has reported earnings of -0.11094200000000001 per share for Q2 2026.

0 Comments

Share your thoughts